Study of TDM-105795 Following Topical Administration in Male Subjects With Androgenetic Alopecia
Public ClinicalTrials.gov record NCT05802173. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Double-blind, Vehicle-controlled, Parallel Group, Multi-dose Study to Evaluate the Efficacy and Safety of TDM-105795 in Male Subjects With Androgenetic Alopecia
Study identification
- NCT ID
- NCT05802173
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Technoderma Medicines Inc.
- Industry
- Enrollment
- 71 participants
Conditions and interventions
Conditions
Interventions
- TDM-105795, 0.0025% Drug
- TDM-105795, 0.02% Drug
- TDM-105795 topical vehicle solution Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years to 55 Years
- Sex
- Male
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Mar 5, 2023
- Primary completion
- Nov 7, 2023
- Completion
- Jan 28, 2024
- Last update posted
- Nov 11, 2025
2023 – 2024
United States locations
- U.S. sites
- 13
- U.S. states
- 9
- U.S. cities
- 13
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site 12 | North Little Rock | Arkansas | 72116 | — |
| Site 4 | Rolling Meadows | Illinois | 60008 | — |
| Site 7 | Plainfield | Indiana | 46168 | — |
| Site 11 | Baton Rouge | Louisiana | 70809 | — |
| Site 13 | New Orleans | Louisiana | 70115 | — |
| Site 10 | Minneapolis | Minnesota | 55455 | — |
| Site 9 | New Brighton | Minnesota | 55112 | — |
| Site 3 | Portland | Oregon | 97210 | — |
| Site 5 | Knoxville | Tennessee | 37909 | — |
| Site 8 | Murfreesboro | Tennessee | 37130 | — |
| Site 1 | Austin | Texas | 78759 | — |
| Site 6 | College Station | Texas | 77845 | — |
| Site 2 | Norfolk | Virginia | 23502 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT05802173, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Nov 11, 2025 · Synced Jul 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT05802173 live on ClinicalTrials.gov.